This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biontech Se. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Bodo Tillmann: Innovator in IL2 Agonists
Introduction
Bodo Tillmann is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of IL2 agonists. His work is instrumental in advancing therapeutic options for various medical conditions.
Latest Patents
Bodo Tillmann holds a patent for IL2 agonists, showcasing his innovative approach to enhancing immune responses. This patent represents a crucial step in the ongoing research and development of immunotherapies.
Career Highlights
Bodo Tillmann is currently associated with BioNTech SE, a leading biotechnology company known for its pioneering work in mRNA technology and cancer immunotherapy. His role at BioNTech SE allows him to collaborate with some of the brightest minds in the industry.
Collaborations
Some of his notable coworkers include Lena Mareen Kranz and Sina Fellermeier-Kopf. Their collective expertise contributes to the innovative environment at BioNTech SE.
Conclusion
Bodo Tillmann's contributions to the field of biotechnology, particularly through his patent on IL2 agonists, highlight his role as a key innovator. His work continues to influence the development of new therapeutic strategies.